Malaria vaccine deployment in Africa: focus on Ghana

Affiliations

¹ Kintampo Health Research Centre, Kintampo, Ghana kwakupoku.asante@kintampo-hrc.org.
² School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana fred.binka@gmail.com.
³ Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana kkoram@noguchi.ug.edu.gh.

Editorial

Kwaku Poku Asante et al. Ghana Med J. 2019 Jun.

. 2019 Jun;53(2):90-91.

doi: 10.4314/gmj.v53i2.2.

¹ Kintampo Health Research Centre, Kintampo, Ghana kwakupoku.asante@kintampo-hrc.org.
² School of Public Health, University of Health and Allied Sciences, Hohoe, Ghana fred.binka@gmail.com.
³ Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana kkoram@noguchi.ug.edu.gh.

No abstract available

Conflict of interest statement

Conflict of interest: None declared

1. Kummervold PE, Schulz WS, Smout E, Fernandez-Luque L, Larson HJ. BMC Public Health. 2017 Aug 7;17(1):642. doi: 10.1186/s12889-017-4618-8. - DOI - PMC - PubMed
1. [14 June 2019]. https://www.ema.europa.eu/en/documents/medicine- outside-eu/mosquirix-su....
1. RTS,S Clinical Trials Partnership, author. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial. Lancet. 2015 Jul 4;386(9988):31–45. doi: 10.1016/S0140-6736(15)60721-8. Epub 2015 Apr 23. - DOI - PMC - PubMed